Title : VAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate.

Pub. Date : 2008 Dec

PMID : 18669979






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Whereas fenofibrate reduced cholesterol mass within VLDL and IDL, and shifted cholesterol from dense LDL subfractions into the more buoyant subfractions and HDL, ezetimibe/simvastatin reduced cholesterol mass within all apolipoprotein B-containing particles without significantly shifting the LDL particle distribution profile. Simvastatin apolipoprotein B Homo sapiens